Amolyt Pharma

0 followers


Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat a... Read more

Headquarters

Écully, France

Employees

11-50

Links

Org chart

Aurélie MILLERAT
Manager, Clinical Data Management
Clémentine Chalmey
Non clinical manager
Damien Aumaille
CMC Drug Product Manager
Delphine Martinez
General Counsel
Guillaume Ravel, PharmD, PhD, DABT
Director, Preclinical Development
Héloïse Boullet
Innovation Manager
Laetitia Ouafki
Director of Quality Assurance
Michael Culler
Chief Scientific Officer
Patrick Loustau
Chief Business Officer
Caroline Robo (Fesquet)
Director Regulatory Affairs
Blandine WEISS
Director Global Medical Affairs
michel ovize
Senior Medical Director
Benedicte Gagnere
Directeur Administratif Et Financier